Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety (rTMSinCP)
A Randomized Open-Label Pilot Trial To Evaluate The Safety And Efficacy Of Repetitive Transcranial Magnetic Stimulation In Cancer Patients With Depression And Anxiety
Sponsor: Neuronetics
Listed as NCT01701284, this NA trial focuses on Anxiety and Cancer in Remission (Any Type or Stage) and remains completed. Sponsored by Neuronetics, it has been updated 11 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Feb 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jul 2019 — Aug 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Nov 2018 — Jul 2019 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Dec 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Neuronetics
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .